Literature DB >> 11984581

Nicotinic receptors: addiction's smoking gun?

Ann E Kelley.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11984581     DOI： 10.1038/nm0502-447

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

1.  Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats.

Authors:  Grazyna Biala; Natasza Staniak; Barbara Budzynska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-10       Impact factor: 3.000

2.  The use-dependent, nicotinic antagonist BTMPS reduces the adverse consequences of morphine self-administration in rats in an abstinence model of drug seeking.

Authors:  Brandon J Hall; Laura S Pearson; Alvin V Terry; Jerry J Buccafusco
Journal:  Neuropharmacology       Date:  2011-05-30       Impact factor: 5.250

3.  Roles of pedunculopontine tegmental cholinergic receptors in brain stimulation reward in the rat.

Authors:  J Chen; M Nakamura; T Kawamura; T Takahashi; D Nakahara
Journal:  Psychopharmacology (Berl)       Date:  2005-12-30       Impact factor: 4.530

Review 4.  Pediatric obesity: parallels with addiction and treatment recommendations.

Authors:  Michelle C Acosta; Jeanne Manubay; Frances R Levin
Journal:  Harv Rev Psychiatry       Date:  2008       Impact factor: 3.732

Review 5.  Rimonabant for treating tobacco dependence.

Authors:  Michael B Steinberg; Jonathan Foulds
Journal:  Vasc Health Risk Manag       Date:  2007

6.  Varenicline in the treatment of tobacco dependence.

Authors:  Karl Fagerström; John Hughes
Journal:  Neuropsychiatr Dis Treat       Date:  2008-04       Impact factor: 2.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.